Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cellular and Molecular Life Sciences Publication

Faron Pharmaceuticals Ltd. (“Faron”)   Cellular and Molecular Life Sciences Publishes Research on Inhibition of Vascular Adhesion Protein-1 Enabling the Expansion of Hematopoietic Stem Cells       Company announcement, November 3, 2021   TURKU, FINLAND / BOSTON, MA – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, today announces that the multidisciplinary journal Cellular and

Peptonic signs contract amendment with Orion Corporation regarding the distribution of Peptonic's intimate wash in Finland

Peptonic Medical (publ) today announced that the company has signed a contract amendment with Orion Corporation in Finland. The amendment concerns Peptonic's Moisturizing V Cleanser for the Finnish market where the product will be sold under Orion's own brand Femisan®️.Orion Corporation has been selling Peptonic's gel for the treatment of vaginal atrophy under the brand Femisan®️ Vital since spring 2019. Since Orion mainly sell through physical pharmacies, sales have been negatively impacted during the pandemic. However, Orion again sees upward trends in the market and now expands its

Qlife’s first scientific study of its COVID-19 test on the mobile Egoo Health system published in Natures Scientific Reports

Qlife announces today that the scientific study of the company's COVID-19 test has been accepted for publication in Natures Scientific Reports. The study demonstrates the potential of Qlife's mobile test platform Egoo.Health and COVID-19 tests that can deliver almost the same clinical quality as laboratory tests in 30 minutes.Today, most people get their diagnosis through so-called quantitative polymerase chain reaction (qRT-PCR) which is performed in specialized laboratories. This means that it often takes more than 24 hours from test to diagnosis. The Scientific study contains the

#21-364 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-363 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Calmark presents at Redeye Life Science Day 2021

Calmark attends the digital event Redeye Life Science Day 2021 that will be held on November 11. CEO Anna Söderlund presents the latest developments and the future prospects for the company at 11:20. The presentation is held in Swedish and will be broadcast live.Redeye’s Life Science Day on November 11 will again be held digitally and provides space to ask questions and have in-depth discussions about the invited companies and their respective areas. The event takes place between 8:30 - 17:00 in three different streams. Two streams of company presentations followed by a Q&A session with

Pagero sees growing demand as Saudi Arabia mandate approaches

With the 4 December deadline of the Saudi Arabia e-invoicing mandate approaching, Pagero is experiencing a significant increase in market interest – both locally and internationally.In December 2020, the Zakat, Tax and Customs Authority (ZATCA) announced a country wide e-invoicing mandate. With the aims to reduce shadow economy, increase adaption of tax returns and to promote fair business competition, all tax paying businesses are mandated to generate, store and report invoices electronically. There is a phased roll out planned with the first deadlines starting from 4 December 2021.

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT OCTOBER 2021

Zinzino group revenue decreased with a total of 3%, compared with the previous year.The revenue in October for Zinzino's sales markets stayed on the same level as last year and amounted to SEK 101.2 (100.8) million. Faun Pharma's external sales decreased by 46% and amounted to SEK 3.7 (6.9) million. Overall, the Group decreased revenues by 3% to SEK 104.9 (107.7) million compared with the previous year. Accumulated revenue for January – October 2021 increased by 19% to SEK 1074.3 (905.9) million. Revenues were distributed as follows: Regions,MSEK 21-okt 20-okt Change YTD

Viable Cities launches global city-focused climate innovation competition

Viable Cities, UN-Habitat and many partners from Sweden and beyond, today launched the Climate Smart Cities Challenge at the Swedish Pavilion at Expo 2020 Dubai to accelerate the shift to climate neutral cities.The Climate Smart Cities Challenge invites innovative organisations of different types and sizes to submit their best approaches, solutions and technologies to reduce carbon emissions while providing positive impacts on the quality of life in four cities – Bogota, Colombia; Bristol, United Kingdom; Curitiba, Brazil and Makindye Ssabagabo, Uganda. The climate challenges of these

Idemia’s VISA and Mastercard certifications fully validate the core components of Zwipe Pay ONE

OSLO, NORWAY – 3 November 2021 - Zwipe’s technology partner, Idemia, has announced that it has obtained full certification from both VISA and Mastercard for its F.CODE biometric payment card.  These certifications (Letters of Approval) represent full validation of the core components in our disruptive technology platform, Zwipe Pay ONE, notably the shared single silicon biometric secure element, where Idemia and Zwipe have co-invested since Q4 2019, and the IDX3405 fingerprint sensor from Idex Biometrics.   This paves the way for subsequent successful certification of Zwipe Pay ONE

Mandatory notification of trade – primary insider

The following primary insider in Multiconsult ASA has purchased shares in Multiconsult ASA: Bård Mikkelsen, Chairman of the Board in Multiconsult ASA, has on 3 November 2021 purchased 5 000 shares in Multiconsult ASA at an average price of NOK 154.7527 per share and will after the transaction hold 22 933 shares in Multiconsult ASA.For further information, please contact:  Investor relations:   Pål-Sverre Jørgensen, Group Treasurer & Investor Relations Officer   Phone: +47 416 11 161   E-mail: ir@multiconsult.no / psmj@multiconsult.no Media:   Gaute Christensen, VP

NCC sells land in Järva Krog to Aros Bostad

NCC sells land in Järva Krog, Solna, to Aros Bostad for approximately SEK 260 million. The purchase includes development rights corresponding to about 190 new residential units that Aros Bostad will construct with NCC as the turnkey contractor. Illustration: NCC’s development area in Järva krog, image Aerial NCC will sell land together with housing development rights in Järva Krog to Aros Bostad for approximately SEK 260 million. The sale is taking place as a stock transfer agreement and the deal is expected to generate a positive earnings effect in the Property Development

Aros Bostad acquires part of “Femöringen” from NCC – corresponding to 190 new residential units in Solna

Aros Bostadsutveckling AB publ (”Aros Bostad”) has acquired building rights, corresponding to c. 190 new residential units within the property Femöringen in Solna, for c. SEK 260 million. NCC is the seller of the land and will be the turnkey contractor for the construction of the new residential project.The building rights constitute the second phase of residential units within Solna’s new city district, where new residentials, service and modern offices are being developed. The location is excellent from both a communications and recreations perspective, with direct access to buses,

Readly completes the acquisition of Toutabo, the owner of ePresse

Readly International AB (publ) (“Readly''), the European category leader within digital magazine subscriptions, has as of November 2, completed the acquisition of 97.3% of the issued shares in Toutabo SA (“Toutabo”, “the Acquisition”), which was announced through a press release on 5 October 2021. The total purchase price amounts to a maximum of EUR 8.2 million on a cash and debt free basis (following certain post signing adjustments), where EUR 3.9 million has been paid today and with an earn-out consideration of up to approximately EUR 4.3 million to be paid at a later time, subject to

Nomination Committee appointed in respect of AGM 2022 in Alligator Bioscience AB

Lund, Sweden, November 3, 2021– Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that the Nomination Committee in preparation for the Annual General Meeting (AGM) on May 5, 2022, has been appointed. Pursuant to the instruction for the Nomination Committee adopted by the AGM on June 1, 2021, the Nomination Committee for the Alligator Bioscience AGM 2022 shall consist of four members, representing the three largest shareholders at the last weekday of June, together with the Chairman of the Board. If a shareholder does not exercise its right to appoint a member, entitlement to

Smoltek has achieved proof-of-concept of its nanofiber-based cell material for electrolyzers

This press release is an English version of the previously published Swedish version, which has interpretive precedence. Smoltek Nanotech Holding AB (“Smoltek”) announces that the company has achieved proof of concept for its high-performing, nanofiber-based cell material for PEM-electrolyzers. This means that the company has demonstrated in a laboratory environment that the cell material fulfils several important performance and durability requirements, including very low contact resistance, which potential industrial partners have stated that they want to test before a collaboration

Notification of Executive’s transaction with Vestas shares

Vestas Wind Systems A/S, Aarhus, 03 November 2021Company announcement no. 19/2021  In accordance with Article 19 (3) of the EU Market Abuse Regulation, Vestas Wind Systems A/S is required to disclose information regarding trading in Vestas Wind Systems A/S shares and securities by Executives and persons closely associated with an Executive. The statement is based on a report which Vestas Wind Systems A/S has received from one of the Executives, see appendix. Contact detailsVestas Wind Systems A/S, Denmark Mathias Dalsten, Vice PresidentInvestor RelationsTel: +45 2829

Selvaag Bolig ASA: Invitation to presentation of third quarter 2021 results

Selvaag Bolig ASA will publish its third quarter 2021 results Thursday 11 November at 07:00 am CET. The quarterly report and the presentation materials will be available on the company's website, www.selvaagboligasa.no/en and www.newsweb.no, as well as news wires. CEO Sverre Molvik and CFO Christopher Brunvoll will present the company's results at 08:30 am CET at Høyres Hus, Stortingsgaten 20 in Oslo. A light breakfast will be served from 08:00. The presentation will be held in Norwegian and transferred via live webcast. Link to the webca 

Interim report 1–9/2021 to be released 10 November 2021

SITOWISE GROUP PLC INVESTOR NEWS 3 NOVEMBER 2021 Sitowise will publish its January–September 2021 report on Wednesday 10/11/2021 at 8:30 am (EET). The stock exchange release and the reporting materials in Finnish and in English will be available at that time at www.sitowise.com  Briefing for analysts, media, and investors Sitowise's CEO Pekka Eloholma and CFO Heidi Karlsson will present the company's Q3 2021 results in English in a conference call and live webcast on 10/11/2021 starting at 1:00 pm (EET). Webcast

Neonode to Report Third Quarter 2021 Results on November 10, 2021

STOCKHOLM, SWEDEN, November 3, 2021 — Neonode Inc. (NASDAQ: NEON), announced today that it will release the financial results for the three and nine months ended September 30, 2021, on Wednesday November 10, 2021. The Company will host a conference call Wednesday November 10, 2021, at 10AM Eastern Standard Time (EST)/4PM Central European Time (CET) featuring remarks by, and Q&A with, Urban Forssell, CEO, Fredrik Nihlén, CFO and David Brunton, Head of Investor Relations. The dial-in numbers for the conference call are toll-free: (800) 895-3361 (U.S. domestic), +1 (785) 424-1062 (

BioStock: Xintela approaches the market with EQSTEM

Drug development company Xintela continues to take steps towards the market with the stem cell product EQSTEM. Recently, a preclinical study was completed showing that the product reduces lameness in horses that have osteoarthritis due to joint injury. Based on these results, the company continues to develop EQSTEM towards market approval. BioStock reached out to Professor Casper Lindegaard, who was involved in the horse study with EQSTEM, for a comment.Read the full interview with Professor Casper Lindegaard at biostock.se: https://www.biostock.se/en/2021/11/xintela-approaches-the-

Artificial Solutions implements Gavriella Schuster’s #BeCOME framework to expand work on inclusion and gender equality

Gavriella Schuster – former Corporate VP of Microsoft in charge of its global portfolio of channel partners – also Chairman of Artificial Solutions’ Advisory Board.Artificial Solutions® (SSME: ASAI ) announces today a partnership with Gavriella Schuster  to #BeCOME  #ALLIES, to accelerate its work on inclusion and gender equality. Artificial Solutions is committed to diversity and equality and has managed to achieve a ratio of 38% women in senior positions. As we continue to grow

EQT Exeter completes USD 6.8 billion industrial portfolio sale - among the largest in US history

· One of the largest US industrial real estate transactions ever, the portfolio consists of 328 high-quality, modern supply chain and e-commerce facilities totaling 70.5 million square feet, assembled through more than 100 transactions over three years  · EQT Exeter raised occupancy in the constructed and standing assets from 55 percent initially to 95 percent at sale and increased the average unleveraged yield on cost from 4.8 percent initially to 6.9 percent  · EQT Exeter, with its unique operating capabilities in the industry, will continue to lease, property manage, and asset

BAKKAFROST: Invitation to Webcast of Q3 2021 results 9 November 2021 at 8:00 am (CET)

A presentation of Bakkafrost's interim report Q3 2021 will be held at 8:00 am (CET) on 9 November 2021. The presentation will be transmitted live on Bakkafrost's website www.bakkafrost.com. Bakkafrost´s interim report Q3 2021 and presentation will be released prior to market opening on 9 November 2021 at 6:00 am (CET). Contacts: · Regin Jacobsen, CEO of P/F Bakkafrost: +298 235001 (mobile) · Høgni Dahl Jakobsen, CFO of P/F Bakkafrost: +298 235060 (mobile) This information is subject of the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading

There are no items matching the current filter
There are no more items matching the current filter
Back to top